1Hormone Laboratory, Department of Physiology, UFR Broussais Hotel Dieu, Paris, France.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers explored spironolactone modifications for mineralocorticoid receptor (MCR) ligands, but found no clinical improvements over existing drugs. In vitro affinity did not predict in vivo potency, challenging hormone action theories.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: